Stock Scorecard
Stock Summary for Johnson & Johnson (JNJ) - $209.72 as of 1/13/2026 3:02:40 PM EST
Total Score
9 out of 30
Safety Score
58 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for JNJ
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for JNJ
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for JNJ
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for JNJ
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for JNJ (58 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 6 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for JNJ
Financial Details for JNJ
Company Overview |
|
|---|---|
| Ticker | JNJ |
| Company Name | Johnson & Johnson |
| Country | N/A |
| Description | Johnson & Johnson (JNJ) is a premier American multinational corporation founded in 1886, encompassing a wide-ranging portfolio in medical devices, pharmaceuticals, and consumer health products. Renowned for its commitment to innovation and quality, J&J plays a pivotal role in the global healthcare landscape, consistently ranking among the most valuable companies worldwide. As a cornerstone of the Dow Jones Industrial Average and boasting an esteemed AAA credit rating, the company exemplifies financial stability and operational proficiency. Positioned 36th on the Fortune 500 list, Johnson & Johnson is strategically focused on sustainable growth while continuing to deliver reliable health solutions to a diverse global market. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - GENERAL |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 1/21/2026 |
Stock Price History |
|
| Last Day Price | 209.72 |
| Price 4 Years Ago | 161.29 |
| Last Day Price Updated | 1/13/2026 3:02:40 PM EST |
| Last Day Volume | 10,818,835 |
| Average Daily Volume | 7,917,098 |
| 52-Week High | 215.19 |
| 52-Week Low | 137.89 |
| Last Price to 52 Week Low | 52.09% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 19.62 |
| Sector PE | 123.98 |
| 5-Year Average PE | 17.03 |
| Free Cash Flow Ratio | 27.70 |
| Industry Free Cash Flow Ratio | 27.83 |
| Sector Free Cash Flow Ratio | 29.04 |
| Current Ratio Most Recent Quarter | 1.07 |
| Total Cash Per Share | 7.57 |
| Book Value Per Share Most Recent Quarter | 32.95 |
| Price to Book Ratio | 6.31 |
| Industry Price to Book Ratio | 6.07 |
| Sector Price to Book Ratio | 24.69 |
| Price to Sales Ratio Twelve Trailing Months | 5.38 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.96 |
| Sector Price to Sales Ratio Twelve Trailing Months | 19.33 |
| Analyst Buy Ratings | 9 |
| Analyst Strong Buy Ratings | 4 |
Share Statistics |
|
| Total Shares Outstanding | 2,409,295,000 |
| Market Capitalization | 505,277,347,400 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 2/24/2026 |
| Previous Dividend Amount | 1.3000 |
| Current Dividend Amount | 1.3000 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 5.14 |
| Trailing Annual Dividend Yield | 2.50% |
| Forward Annual Dividend Rate | 5.20 |
| Forward Annual Dividend Yield | 2.53% |
| 5-Year Dividend Payments Count | 21 |
| 3-Year Average Dividend Yield | 2.48% |
| 5-Year Average Dividend Yield | 2.98% |
| 1-Year Dividend Growth Rate Percentage | 1.17% |
| 3-Year Dividend Growth Rate Percentage | 0.58% |
| 5-Year Dividend Growth Rate Percentage | 3.97% |
| All-Time Dividend Growth Rate Percentage | 12.87% |
| Dividend Payout Ratio | 49.66% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 91.00% |
| Annual Earnings Growth | -59.99% |
| Reported EPS 12 Trailing Months | 10.35 |
| Reported EPS Past Year | 8.34 |
| Reported EPS Prior Year | 9.48 |
| Net Income Twelve Trailing Months | 25,119,000,000 |
| Net Income Past Year | 14,066,000,000 |
| Net Income Prior Year | 35,153,000,000 |
| Quarterly Revenue Growth YOY | 6.80% |
| 5-Year Revenue Growth | 1.60% |
| Operating Margin Twelve Trailing Months | 30.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 18,231,000,000 |
| Total Cash Past Year | 24,105,000,000 |
| Total Cash Prior Year | 21,859,000,000 |
| Net Cash Position Most Recent Quarter | -21,177,000,000 |
| Net Cash Position Past Year | -6,546,000,000 |
| Long Term Debt Past Year | 30,651,000,000 |
| Long Term Debt Prior Year | 25,881,000,000 |
| Total Debt Most Recent Quarter | 39,408,000,000 |
| Equity to Debt Ratio Past Year | 0.70 |
| Equity to Debt Ratio Most Recent Quarter | 0.67 |
| Total Stockholder Equity Past Year | 71,490,000,000 |
| Total Stockholder Equity Prior Year | 68,774,000,000 |
| Total Stockholder Equity Most Recent Quarter | 79,277,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 19,064,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 7.91 |
| Free Cash Flow Past Year | 19,842,000,000 |
| Free Cash Flow Prior Year | 18,248,000,000 |
Options |
|
| Put/Call Ratio | 0.52 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.33 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 155.61 |
| 200-Day SMA | 155.73 |
System |
|
| Modified | 1/13/2026 11:43:00 PM EST |